Skip to main content

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Molecular and Cellular Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1550032

Examination of the Functions and Mechanism of KCP in Mediating Paclitaxel Resistance in Cervical Squamous Carcinoma Cells

Provisionally accepted
Yue He Yue He Jian-Qing Xu Jian-Qing Xu Jing-Jing Zhang Jing-Jing Zhang Zhen-You Liu Zhen-You Liu Chen Ji Chen Ji Yang Liu Yang Liu Yun-Fan Wang Yun-Fan Wang Ming Wang Ming Wang Yumei Wu Yumei Wu *Yan Wang Yan Wang *
  • Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China

The final, formatted version of the article will be published soon.

    Objective: To evaluate the mechanism of Kielin/chordin-like protein (KCP) in the resistance of cervical cancer cells to paclitaxel.Method:A cervical squamous carcinoma cell line (SiHa) with KCP knockout was constructed and treated with paclitaxel. Key cell functions were assessed by colony formation assay, measurement of cell proliferation by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, and FACS-based detection of apoptosis. The downstream mechanism of KCP-mediated resistance to paclitaxel was then examined using human gene chip detection and IPA bioinformatics analysis, and qPCR analysis was used to validate its downstream genes.Results: ①Functional studies of SiHa cells showed that KCP knockout (sgRNA) inhibited colony formation and proliferation of SiHa cells in the presence of paclitaxel (p<0.05). ②Using a whole human genome microarray, a total of 491 differentially expressed genes were identified in KCP knockout versus the NC SiHa cells. IPA-based bioinformatics analysis of upstream regulators showed that SPI1 was strongly activated and that SPI1 inhibited CCND1 and activated Pml and CEBPA, which is consistent with results from gene chip analysis showing CCND1, Pml, and CEBPA expression after KCP knockout. ③A total of 30 differentially expressed genes associated with tumor cell proliferation were identified by gene microarray and IPA analyses. The changes in the aforementioned genes after KCP knockout were verified by qPCR, and SERPINB3 and CEBPA expression were significantly lower and higher, respectively, compared to in the control group.KCP increased resistance of cervical cancer to paclitaxel by enhancing cell proliferation and colony formation. We observed that KCP could act positively on the downstream gene SERPINB3 and negatively on the downstream gene CEBPA to affect the resistance of cervical carcinoma cells to paclitaxel.

    Keywords: Kielin/chordin-like protein, paclitaxel resistance, Cervical squamous cell carcinoma, Mechanism, Functions

    Received: 31 Dec 2024; Accepted: 26 Mar 2025.

    Copyright: © 2025 He, Xu, Zhang, Liu, Ji, Liu, Wang, Wang, Wu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Yumei Wu, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China
    Yan Wang, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more